국가: 아일랜드
언어: 영어
출처: HPRA (Health Products Regulatory Authority)
Trimethoprim; Sulfadiazine
Norbrook Laboratories Limited
QJ01E
Trimethoprim; Sulfadiazine
percent
Oral paste
POM: Prescription Only Medicine as defined in relevant national legislation
Horses
SULFONAMIDES AND TRIMETHOPRIM
Antibacterial
Authorised
1988-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Norodine Equine Oral Paste. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Oral paste. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Norodine Equine Paste is indicated in the treatment of bacterial infections in horses caused by sensitive micro- organisms including:- _Escherichia coli_ _Staphylococcus spp._ _Streptococcus spp._ 4.3 CONTRAINDICATIONS Contraindicated in horses with known sulphonamide sensitivity and also in animals with hepatic damage or blood dyscrasias. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES No special precautions. Each 4.31g dose contains: Active Substances Trimethoprim 5.80 %w/w Sulfadiazine 28.83 %w/w Excipients Methyl Parahydroxybenzoate (E218) 0.18 %w/w Propyl Parahydroxybenzoate (E216) 0.02 %w/w H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _2_ _/_ _1_ _1_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _5_ _0_ _6_ _9_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTION(S) FOR USE IN ANIMALS Do not use the same syringe to treat more than one animal unless horses are running together or in direct contact with each other on the same premises. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS None. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) No undesirable effects. 4.7 USE DURING PREGN 전체 문서 읽기